177-lutetium PNT-2001(POINT Biopharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Name177-lutetium PNT-2001(POINT Biopharma)
Drug Alias Name177Lu-PNT2001PNT-2001-Lu-177-isotopePNT-2001 lutetium 177 isotope177-Lu-PNT-2001
ClassificationRadiation-emitting products
Mechanisms of ActionIonising radiation emitters
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScintomicsPoint Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesScintomicsPoint Biopharma Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A